Copyright
©The Author(s) 2024.
World J Gastroenterol. Jul 14, 2024; 30(26): 3210-3220
Published online Jul 14, 2024. doi: 10.3748/wjg.v30.i26.3210
Published online Jul 14, 2024. doi: 10.3748/wjg.v30.i26.3210
Table 1 Basic demographics of the study population
Features | n of 605 | % |
Age, mean ± SD (58.2 ± 19), median = 60 | ||
< 60 years | 294 | 48.6 |
≥ 60 years | 311 | 51.4 |
Sex | ||
Female | 297 | 49.2 |
Male | 307 | 50.8 |
Duration of symptoms | ||
< 30 days | 330 | 62.6 |
30-59 days | 75 | 13.2 |
60-89 days | 11 | 7.3 |
≥ 90 days | 14 | 9.3 |
Control without alarm features | 92 | 15.2 |
Patients with alarm features | 513 | 84.8 |
Alarm features | ||
Upper GI bleeding | 144 | 23.8 |
Unexplained weight loss | 137 | 22.6 |
Persistent vomiting | 124 | 20.5 |
Iron deficiency anemia | 50 | 8.3 |
Dysphagia | 37 | 6.1 |
Odynophagia | 5 | 0.8 |
Epigastric mass or lymphadenopathy | 1 | 0.2 |
Endoscopic finding | ||
Patients without endoscopic finding | 431 | 71.2 |
Patients with any endoscopic finding | 174 | 28.8 |
Peptic ulcer disease | 92 | 15.2 |
Erosive esophagitis class B or higher | 34 | 5.6 |
Malignancy | 42 | 6.9 |
Stricture | 1 | 0.2 |
Finding requiring specific therapy | 15 | 2.5 |
Medications | ||
PPIs | 173 | 29 |
Statins | 191 | 32.3 |
Aspirin | 111 | 18.8 |
Anticoagulant | 39 | 6.6 |
Anti-aggregate | 30 | 5.1 |
NSAIDs | 23 | 3.9 |
- Citation: Ibrahim L, Basheer M, Khoury T, Sbeit W. Yield of alarm features in predicting significant endoscopic findings among hospitalized patients with dyspepsia. World J Gastroenterol 2024; 30(26): 3210-3220
- URL: https://www.wjgnet.com/1007-9327/full/v30/i26/3210.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i26.3210